Rapid onset opioids in palliative medicine

Area of Science:

• Pharmacology
• Pain Management
• Drug Development

Background:

• Opioids are effective analgesics for various pain conditions.
• Opioid classification includes natural, semisynthetic, and synthetic categories.
• Pharmacokinetic properties, such as onset and duration, guide opioid selection.

Purpose of the Study:

• To review pharmacokinetic classifications of opioids.
• To highlight the utility of rapid onset opioids for specific pain types.
• To present five U.S. Food and Drug Administration-approved rapid onset opioids.

Main Methods:

• Literature review of opioid classifications.
• Focus on pharmacokinetic properties of opioid formulations.
• Identification of FDA-approved rapid onset opioids.

Main Results:

• Rapid onset opioids are particularly suited for breakthrough pain.
• Specific pharmacokinetic profiles aid in matching opioids to pain types.
• Five distinct rapid onset opioid products are available in the U.S.

Conclusions:

• Rapid onset opioids represent a valuable therapeutic option for breakthrough pain.
• Understanding opioid pharmacokinetics is crucial for effective pain management.
• This review provides an overview of key rapid onset opioid agents.